Evidence map›Paper›PMID 39927104›Full record

ReviewACS organic & inorganic Au2025

Applications of Antimony in Catalysis.

Lewen Wu, Choon-Hong Tan, Xinyi Ye

Abstract readReview
In one paragraph

Review in ACS organic & inorganic Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Beyond BODIPY: dipyrrin complexes of P-block elements.Journal of coordination chemistry · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lewen WuCollege of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, 18 Chaowang Road, Hangzhou 310014, P. R. China.
Choon-Hong TanSchool of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore.ORCID https://orcid.org/0000-0003-3190-7855
Xinyi YeCollege of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, 18 Chaowang Road, Hangzhou 310014, P. R. China.ORCID https://orcid.org/0000-0002-5344-9122

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimony is a fifth-period element in the nitrogen family, a silver-white metalloid with weak conductivity and thermal conductivity. It is stable at room temperature and does not react easily with oxygen and water in the air. Natural minerals are found in the form of sulfides. Current research and applications are mostly concentrated on material modification, utilizing the properties of antimony in traditional chemical industries, helping alloys improve their flame retardancy, stability, increasing semiconductor performance, etc. For example, to enhance the electronic conductivity, after coating or embedding antimony or its derivatives in thin layers in photonic nanomaterials, the performance of the original material in photoelectrochemical catalysis can be effectively increased, thereby expanding the efficiency of oxidation-reduction reactions accounting for the degradation of organic matter in wastewater. However, the catalytic reaction between the derivatives of antimony and organic compounds beside the material is less studied, and the mechanism of the studies in organic synthesis is relatively unclear. The reported organic synthesis related to antimony is mainly in the form of Lewis acid catalysts or dual-metal catalytic systems combined with other metals. This Review will focus on the application of antimony in photocatalysis, electrocatalysis, and other organic syntheses in the past 10 years.

Identifiers

PMID39927104
PMCPMC11803468

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.